000			01693 a2200469 4500
005			20250512113206.0
264		0	_c19750703
008			197507s 0 0 eng d
022			_a0375-9997
040			_aNLM _beng _cNLM
100	1		_aLaufman, H
245	0	0	_aEmpiric use of anticoagulant and fibrinolytic agents in surgery. _h[electronic resource]
260			_bThrombosis et diathesis haemorrhagica. Supplementum _c1973
300			_a265-73 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAcute Disease
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aBlood Coagulation Tests
650	0	4	_aCardiac Surgical Procedures
650	0	4	_aCoronary Artery Bypass
650	0	4	_aDextrans _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFibrinolytic Agents _xpharmacology
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHeparin _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInfusions, Parenteral
650	0	4	_aInjections, Subcutaneous
650	0	4	_aPostoperative Complications _xprevention & control
650	0	4	_aPregnancy
650	0	4	_aPregnancy Complications, Hematologic _xdrug therapy
650	0	4	_aProthrombin _xantagonists & inhibitors
650	0	4	_aProthrombin Time
650	0	4	_aPulmonary Embolism _xdrug therapy
650	0	4	_aSurgical Procedures, Operative
650	0	4	_aThromboembolism _xprevention & control
650	0	4	_aThrombophlebitis _xdrug therapy
650	0	4	_aThrombosis _xprevention & control
650	0	4	_aVascular Surgical Procedures
650	0	4	_aWarfarin _xadverse effects
773	0		_tThrombosis et diathesis haemorrhagica. Supplementum _gvol. 56 _gp. 265-73
999			_c4553303 _d4553303